NNNN
Anbio Biotechnology Class A Ordinary Shares
NNNN
NNNN
3 hedge funds and large institutions have $496K invested in Anbio Biotechnology Class A Ordinary Shares in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
$325K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
$127K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$42.8K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Marshall Wace
London,
United Kingdom
| $325K | +$325K | +43,629 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $127K | +$127K | +17,060 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $42.8K | +$42.8K | +5,738 | New |
|